These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 38677751)
1. Diagnostic Value of Immunostaining for Thyroid Transcription Factor 1 (TTF1) and Paired Box 8 (PAX8) in Distinguishing Pulmonary Metastases of Mesonephric and Mesonephric-like Adenocarcinomas from Primary Lung Adenocarcinomas. Ji N; Lee Y; Lee SH; Kim HS Anticancer Res; 2024 May; 44(5):2159-2170. PubMed ID: 38677751 [TBL] [Abstract][Full Text] [Related]
2. Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-β. Kenny SL; McBride HA; Jamison J; McCluggage WG Am J Surg Pathol; 2012 Jun; 36(6):799-807. PubMed ID: 22456609 [TBL] [Abstract][Full Text] [Related]
3. PAX8 expression in uterine adenocarcinomas and mesonephric proliferations. Yemelyanova A; Gown AM; Wu LS; Holmes BJ; Ronnett BM; Vang R Int J Gynecol Pathol; 2014 Sep; 33(5):492-9. PubMed ID: 25083965 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung. Ye J; Hameed O; Findeis-Hosey JJ; Fan L; Li F; McMahon LA; Yang Q; Wang HL; Xu H Biotech Histochem; 2012 Jan; 87(1):30-4. PubMed ID: 21838611 [TBL] [Abstract][Full Text] [Related]
5. A Comparison of GATA3, TTF1, CD10, and Calretinin in Identifying Mesonephric and Mesonephric-like Carcinomas of the Gynecologic Tract. Pors J; Cheng A; Leo JM; Kinloch MA; Gilks B; Hoang L Am J Surg Pathol; 2018 Dec; 42(12):1596-1606. PubMed ID: 30148742 [TBL] [Abstract][Full Text] [Related]
6. Differential patterns of PAX8, p16, and ER immunostains in mesonephric lesions and adenocarcinomas of the cervix. Goyal A; Yang B Int J Gynecol Pathol; 2014 Nov; 33(6):613-9. PubMed ID: 25272301 [TBL] [Abstract][Full Text] [Related]
7. Molecular genetic alterations in thyroid transcription factor 1-negative lung adenocarcinoma in cytology specimens: A subset with aggressive behavior and a poor prognosis. Rodriguez EF; VandenBussche CJ; Chowsilpa S; Maleki Z Cancer Cytopathol; 2018 Oct; 126(10):853-859. PubMed ID: 30199148 [TBL] [Abstract][Full Text] [Related]
8. Premature Classification of Early-stage Endometrioid Ovarian Carcinoma With Mesonephric-like Differentiation as Mesonephric-like Adenocarcinoma. Miyama Y; Ogasawara A; Hasegawa K; Yasuda M Int J Gynecol Pathol; 2024 Jul; 43(4):362-372. PubMed ID: 38870078 [TBL] [Abstract][Full Text] [Related]
9. A comprehensive analysis of PAX8 expression in human epithelial tumors. Laury AR; Perets R; Piao H; Krane JF; Barletta JA; French C; Chirieac LR; Lis R; Loda M; Hornick JL; Drapkin R; Hirsch MS Am J Surg Pathol; 2011 Jun; 35(6):816-26. PubMed ID: 21552115 [TBL] [Abstract][Full Text] [Related]
10. Identifying mesonephric-like adenocarcinoma of the endometrium by combining SOX17 and PAX8 immunohistochemistry. Tahir M; Xing D; Ding Q; Wang Y; Singh K; Suarez AA; Parwani A; Li Z Histopathology; 2025 Jan; 86(2):268-277. PubMed ID: 39233315 [TBL] [Abstract][Full Text] [Related]
11. Value of SATB2, ISL1, and TTF1 to differentiate rectal from other gastrointestinal and lung well-differentiated neuroendocrine tumors. Zhao LH; Chen C; Mao CY; Xiao H; Fu P; Xiao HL; Wang G Pathol Res Pract; 2019 Jul; 215(7):152448. PubMed ID: 31133441 [TBL] [Abstract][Full Text] [Related]
12. SOX10, GATA3, GCDFP15, Androgen Receptor, and Mammaglobin for the Differential Diagnosis Between Triple-negative Breast Cancer and TTF1-negative Lung Adenocarcinoma. Laurent E; Begueret H; Bonhomme B; Veillon R; Thumerel M; Velasco V; Brouste V; Hoppe S; Fournier M; Grellety T; MacGrogan G Am J Surg Pathol; 2019 Mar; 43(3):293-302. PubMed ID: 30628926 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic Characteristics of Mesonephric Adenocarcinomas and Mesonephric-like Adenocarcinomas in the Gynecologic Tract: A Multi-institutional Study. Pors J; Segura S; Chiu DS; Almadani N; Ren H; Fix DJ; Howitt BE; Kolin D; McCluggage WG; Mirkovic J; Gilks B; Park KJ; Hoang L Am J Surg Pathol; 2021 Apr; 45(4):498-506. PubMed ID: 33165093 [TBL] [Abstract][Full Text] [Related]
14. [Adenocarcinomas with mesonephric features in gynecologic tract: a clinicopathological analysis of seven cases]. Liang Y; Ruan HJ; Wang WS; Yu MH; Chen XD; Zhang XF Zhonghua Bing Li Xue Za Zhi; 2021 Jul; 50(7):791-795. PubMed ID: 34405616 [No Abstract] [Full Text] [Related]
15. Negative Thyroid Transcription Factor 1 Expression Defines an Unfavorable Subgroup of Lung Adenocarcinomas. Zhang Y; Wang R; Li Y; Pan Y; Hu H; Zhang Y; Li H; Shen L; Yu Y; Sun Y; Chen H J Thorac Oncol; 2015 Oct; 10(10):1444-50. PubMed ID: 26200450 [TBL] [Abstract][Full Text] [Related]
16. Is TTF1 a good immunohistochemical marker to distinguish primary from metastatic lung adenocarcinomas? Reis-Filho JS; Carrilho C; Valenti C; Leitão D; Ribeiro CA; Ribeiro SG; Schmitt FC Pathol Res Pract; 2000; 196(12):835-40. PubMed ID: 11156325 [TBL] [Abstract][Full Text] [Related]
17. SOX17 expression in mesonephric-like adenocarcinomas and mesonephric remnants/hyperplasia of the female genital tract: Expanding its utility as a Müllerian biomarker. Zhang X; McCluggage WG; Howitt BE; Hirsch MS Histopathology; 2024 Nov; 85(5):820-825. PubMed ID: 39245863 [TBL] [Abstract][Full Text] [Related]
18. Hormone receptor-negative, thyroid transcription factor 1-positive uterine and ovarian adenocarcinomas: report of a series of mesonephric-like adenocarcinomas. McFarland M; Quick CM; McCluggage WG Histopathology; 2016 Jun; 68(7):1013-20. PubMed ID: 26484981 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic use of PAX8, CAIX, TTF-1, and TGB in metastatic renal cell carcinoma of the thyroid. Cimino-Mathews A; Sharma R; Netto GJ Am J Surg Pathol; 2011 May; 35(5):757-61. PubMed ID: 21451364 [TBL] [Abstract][Full Text] [Related]
20. Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung. Ye J; Findeis-Hosey JJ; Yang Q; McMahon LA; Yao JL; Li F; Xu H Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):313-7. PubMed ID: 21464700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]